CD8A and neoplasm: The immunoscore term is identified as the numeration of two lymphocyte populations (CD3/CD45RO, CD3/CD8, or CD8/CD45RO), both in the core of the tumor and in the invasive margin of tumors, as a clinically beneficial prognostic marker in CRC.